PCM
ELV icon

Palisade Capital Management’s Elevance Health ELV Stock Holding History

Palisade Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-21,000
Closed -$2.09M – 478
2014
Q1 		$2.09M Buy
+21,000
New +$1.9M 0.05% 315

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Palisade Capital Management's ELV Position: Q2 2014 in Review

Palisade Capital Management sold out of Elevance Health (ELV) in Q2 2014, closing a stake of 21,000 shares — an estimated $2.09M sold.

Palisade Capital Management first reported a position in ELV in Q1 2014 and held it in 1 quarter. The position peaked at $2.09M in Q1 2014. 687 funds tracked by Wall St. Rank hold ELV as of Q2 2014.

  • Palisade Capital Management reported no remaining Elevance Health position as of Q2 2014 after selling out during the quarter.
  • Palisade Capital Management sold 21,000 Elevance Health shares in Q2 2014, an estimated $2.09M.
  • Palisade Capital Management first reported a position in Elevance Health in Q1 2014 and held it in 1 quarter.
  • Palisade Capital Management's Elevance Health position peaked at $2.09M in Q1 2014.
  • 687 funds tracked by Wall St. Rank held Elevance Health as of Q2 2014.

Based on Palisade Capital Management's 13F filing for Q2 2014, filed 6 Aug 2014.